Eiger BioPharmaceuticals, Inc. (EIGRQ)
OTCMKTS: EIGRQ · Delayed Price · USD
12.50
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market open
Eiger BioPharmaceuticals Market Cap
Eiger BioPharmaceuticals has a market cap or net worth of $18.51 million as of July 22, 2024. Its market cap has decreased by -58.50% in one year.
Market Cap
18.51M
Enterprise Value
34.27M
1-Year Change
-58.50%
Ranking
n/a
Category
Stock Price
Market Cap Chart
Since January 30, 2014, Eiger BioPharmaceuticals's market cap has decreased from $140.60M to $18.51M, a decrease of -86.83%. That is a compound annual growth rate of -18.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2024 | 2.60M | -74.00% |
| Dec 29, 2023 | 10.00M | -80.77% |
| Dec 30, 2022 | 52.00M | -70.50% |
| Dec 31, 2021 | 176.30M | -55.90% |
| Dec 31, 2020 | 399.80M | 9.53% |
| Dec 31, 2019 | 365.00M | 88.14% |
| Dec 31, 2018 | 194.00M | 32.24% |
| Dec 29, 2017 | 146.70M | 50.62% |
| Dec 30, 2016 | 97.40M | 176.70% |
| Dec 31, 2015 | 35.20M | -92.27% |
| Dec 31, 2014 | 455.40M | 223.90% |
| Jan 30, 2014 | 140.60M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 814.94B |
| Novo Nordisk | 579.91B |
| UnitedHealth Group | 520.32B |
| Johnson & Johnson | 372.29B |
| Merck & Co. | 318.55B |
| AbbVie | 304.29B |
| AstraZeneca | 244.04B |
| Novartis AG | 207.64B |